HopeStage
Back to all studies
RecruitingNCT04354077

Study of deep brain stimulation for opioid use disorder

About this title

Deep Brain Stimulation Effects In Patients With Opioid Use Disorder

Read the official source — NCT04354077
Device studyAges 22–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 22 years to 65 years.

Listed locations
PittsburghSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 7, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
3
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Sponsor type
Research institute
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
United States
Age range
From 22 Years to 65 Years
Official registry ID
NCT04354077
Official title
Show the full official title

Pilot Study to Evaluate Deep Brain Stimulation (DBS) of the Nucleus Accumbens (NAc) for Patients With Treatment-refractory Opioid Use Disorder

Recruitment & locations

Currently recruiting

Pittsburgh

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), a research institute.

Who can participate?

Listed age limits: 22 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies